These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9882164)

  • 1. Guillain-Barré syndrome and Campylobacter infection.
    Isaäcson M
    J Travel Med; 1998 Sep; 5(3):160. PubMed ID: 9882164
    [No Abstract]   [Full Text] [Related]  

  • 2. The risk of Guillain-Barré syndrome following infection with Campylobacter jejuni.
    McCarthy N; Andersson Y; Jormanainen V; Gustavsson O; Giesecke J
    Epidemiol Infect; 1999 Feb; 122(1):15-7. PubMed ID: 10098780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Workshop summary and recommendations regarding the development of Guillain-Barré syndrome following Campylobacter infection.
    Lang DR; Allos BM; Blaser MJ
    J Infect Dis; 1997 Dec; 176 Suppl 2():S198-200. PubMed ID: 9396711
    [No Abstract]   [Full Text] [Related]  

  • 4. Guillain-Barré syndrome associated with Campylobacter infection.
    Kuroki S; Haruta T; Yoshioka M; Kobayashi Y; Nukina M; Nakanishi H
    Pediatr Infect Dis J; 1991 Feb; 10(2):149-51. PubMed ID: 2062607
    [No Abstract]   [Full Text] [Related]  

  • 5. The Guillain-Barré syndrome at 75: the Campylobacter connection.
    Griffin JW; Ho TW
    Ann Neurol; 1993 Aug; 34(2):125-7. PubMed ID: 8338335
    [No Abstract]   [Full Text] [Related]  

  • 6. Guillain-Barre syndrome and Campylobacter jejuni infection. A study on the etiological characteristics of Guillain-Barre syndrome in China.
    Yuan JM; Tang J; Chen QT; Xiao L; Hao HJ; Jia ZD; Huang QH; Liu XZ
    Chin Med J (Engl); 1993 Nov; 106(11):845-7. PubMed ID: 8143497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Campylobacter jejuni and Guillain-Barré syndrome.
    Rees JH; Hughes RA
    Ann Neurol; 1994 Feb; 35(2):248-9. PubMed ID: 8109911
    [No Abstract]   [Full Text] [Related]  

  • 8. Campylobacter jejuni infection and Guillain-Barré syndrome.
    Rees JH; Soudain SE; Gregson NA; Hughes RA
    N Engl J Med; 1995 Nov; 333(21):1374-9. PubMed ID: 7477117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Campylobacter jejuni, human immunodeficiency virus, and the Guillain-Barré syndrome.
    Mishu B; Blaser MJ
    J Infect Dis; 1994 May; 169(5):1177. PubMed ID: 8169419
    [No Abstract]   [Full Text] [Related]  

  • 10. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies.
    Ho TW; Mishu B; Li CY; Gao CY; Cornblath DR; Griffin JW; Asbury AK; Blaser MJ; McKhann GM
    Brain; 1995 Jun; 118 ( Pt 3)():597-605. PubMed ID: 7600081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing concepts of Guillain-Barré syndrome.
    Bolton CF
    N Engl J Med; 1995 Nov; 333(21):1415-7. PubMed ID: 7477125
    [No Abstract]   [Full Text] [Related]  

  • 12. Specific serotype of Campylobacter jejuni associated with Guillain-Barré syndrome.
    Fujimoto S; Yuki N; Itoh T; Amako K
    J Infect Dis; 1992 Jan; 165(1):183. PubMed ID: 1727892
    [No Abstract]   [Full Text] [Related]  

  • 13. Campylobacter jejuni Infection and treatment for Guillain-Barré Syndrome.
    Jacobs BC; Schmitz PI; van der Meche FG
    N Engl J Med; 1996 Jul; 335(3):208-9. PubMed ID: 8657230
    [No Abstract]   [Full Text] [Related]  

  • 14. GM1 antibody in Guillain-Barre syndrome after Campylobacter jejuni infection.
    Tang J; Yuan J; Hao H
    Chin Med J (Engl); 1995 Apr; 108(4):262-4. PubMed ID: 7789212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concepts in Guillain-Barré syndrome.
    Franco DA; Bashir RM
    Nebr Med J; 1996 Dec; 81(12):406-11. PubMed ID: 9046790
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-ganglioside antibodies in patients with Guillain-Barré syndrome and Campylobacter jejuni infection.
    Rees JH; Gregson NA; Hughes RA
    J Infect Dis; 1995 Aug; 172(2):605-6. PubMed ID: 7622918
    [No Abstract]   [Full Text] [Related]  

  • 17. The economic burden of Campylobacter-associated Guillain-Barré syndrome.
    Buzby JC; Allos BM; Roberts T
    J Infect Dis; 1997 Dec; 176 Suppl 2():S192-7. PubMed ID: 9396710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guillain-Barré syndrome in South Africa associated with Campylobacter jejuni O:41 strains.
    Lastovica AJ; Goddard EA; Argent AC
    J Infect Dis; 1997 Dec; 176 Suppl 2():S139-43. PubMed ID: 9396698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiologic approaches for studying Campylobacter species in patients with Guillain-Barré syndrome.
    Nachamkin I
    J Infect Dis; 1997 Dec; 176 Suppl 2():S106-14. PubMed ID: 9396692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Campylobacter infection and Guillain-Barré syndrome.
    Allos BM
    J Infect Dis; 1997 Dec; 176 Suppl 2():S125-8. PubMed ID: 9396695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.